| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |